Future Potential of Cord Blood
Research is growing around the use of cord blood stem cells. Currently there are phase I and II clinical trials in the area of regenerative medicine. Many of these studies require the use of an autologous source of stem cells.20,41 Autologous cells are most likely preferred because of the safety concerns related to host rejection with allogeneic units, and autologous stem cells are perfectly designed to repair host’s own tissue. Current emerging research involving the use of autologous cord blood includes:
Type 1 Diabetes 32
Cerebral Palsy 28,29
- Traumatic Brain Injury
Because many clinical trials currently require the use of autologous stem cells, family banking is the only way to ensure access to this emerging research.